Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Feb 27, 2023; 15(2): 211-221
Published online Feb 27, 2023. doi: 10.4240/wjgs.v15.i2.211
Published online Feb 27, 2023. doi: 10.4240/wjgs.v15.i2.211
Characteristics | Immune–nutritional score systems | ||||||
Values (n = 54) | PNI (n = 27/27) | P value | CONUT (n = 34/20) | P value | NPS (n = 32/22) | P value | |
Age (years) | 1.000 | 0.368 | 0.047 | ||||
< 70 | 26 | 13/13 | 18/8 | 19/7 | |||
≥ 70 | 28 | 14/14 | 16/12 | 13/15 | |||
Gender | 1.000 | 0.713 | 0.216 | ||||
Male | 42 | 21/21 | 27/15 | 23/19 | |||
Female | 12 | 6/6 | 7/5 | 9/3 | |||
Primary tumor size | 0.790 | 0.581 | 1.000 | ||||
≤ 3 cm | 27 | 13/14 | 18/9 | 16/11 | |||
> 3 cm | 27 | 14/13 | 16/11 | 16/11 | |||
Gross type | 0.412 | 0.313 | 0.386 | ||||
Non-ulcerative type | 21 | 12/9 | 15/6 | 14/7 | |||
Ulcerative type | 33 | 15/18 | 19/14 | 18/15 | |||
Differentiation | 0.285 | 0.449 | 0.189 | ||||
Well/Moderate | 28 | 16/12 | 19/9 | 19/9 | |||
Poor | 26 | 11/15 | 15/11 | 13/13 | |||
T stage | 0.588 | 0.519 | 0.984 | ||||
T1/T2 | 22 | 12/10 | 15/7 | 13/9 | |||
T3/T4 | 32 | 15/17 | 19/13 | 19/13 | |||
Lymph node metastasis | 0.106 | 0.449 | 0.445 | ||||
No | 28 | 17/11 | 19/9 | 18/10 | |||
Yes | 26 | 10/16 | 15/11 | 14/12 | |||
cTNM status | 0.282 | 0.538 | 0.075 | ||||
I/II | 30 | 17/13 | 20/10 | 21/9 | |||
III | 24 | 10/14 | 14/10 | 11/13 |
Characteristic | OS | ||
HR | 95%CI | P value | |
Age (years) | 0.500 | ||
< 70 | 1.000 | 0.605-2.796 | |
≥ 70 | 1.301 | ||
Gender | 0.451 | ||
Male | 1.000 | 0.261-1.1.816 | |
Female | 0.689 | ||
Primary tumor size | 0.926 | ||
≤ 3 cm | 1.000 | 0.479-2.242 | |
> 3 cm | 1.037 | ||
Gross type | 0.014 | ||
Non-ulcerative type | 1.000 | 1.285-8.932 | |
Ulcerative type | 3.388 | ||
Differentiation | 0.032 | ||
Well/Moderate | 1.000 | 1.083-5.629 | |
Poor | 2.469 | ||
T stage | 0.289 | ||
T1/T2 | 1.000 | 0.671-3.823 | |
T3/T4 | 1.601 | ||
Lymph node metastasis | <0.001 | ||
No | 1.000 | 1.963-10.472 | |
Yes | 4.534 | ||
cTNM stage | 0.001 | ||
I/II | 1.000 | 1.734-9.117 | |
III | 3.976 | ||
PNI group | 0.002 | ||
Low risk | 1.000 | 1.724-10.030 | |
High risk | 4.158 | ||
CONUT group | 0.039 | ||
Low risk | 1.000 | 1.041-4.666 | |
High risk | 2.204 | ||
NPS group | < 0.001 | ||
Low risk | 1.000 | 1.879-9.425 | |
High risk | 4.208 |
- Citation: Zhang Y, Wang LJ, Li QY, Yuan Z, Zhang DC, Xu H, Yang L, Gu XH, Xu ZK. Prognostic value of preoperative immune-nutritional scoring systems in remnant gastric cancer patients undergoing surgery. World J Gastrointest Surg 2023; 15(2): 211-221
- URL: https://www.wjgnet.com/1948-9366/full/v15/i2/211.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i2.211